Contraction and membrane activation in several mammalian vascular muscles.
D000200:Action Potentials; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001011:Aorta / Q000502:physiology; D001158:Arteries / Q000502:physiology; D001808:Blood Vessels / Q000502:physiology*; D002339:Carotid Arteries / Q000502:physiology; D002417:Cattle; D004285:Dogs; D004553:Electric Conductivity; D004558:Electric Stimulation; D005730:Ganglionic Blockers / Q000494:pharmacology; D006168:Guinea Pigs; D006736:Horses; D008564:Membrane Potentials; D008638:Mesenteric Arteries / Q000502:physiology; D008642:Mesenteric Veins / Q000502:physiology; D009119:Muscle Contraction; D009130:Muscle, Smooth / Q000502:physiology*; D009638:Norepinephrine; D009880:Ophthalmic Artery / Q000502:physiology; D010276:Parasympatholytics / Q000494:pharmacology; D011169:Portal Vein / Q000502:physiology; D011651:Pulmonary Artery / Q000502:physiology; D012756:Sheep; D013552:Swine; D014680:Veins / Q000502:physiology
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D005730:Ganglionic Blockers; D010276:Parasympatholytics; D009638:Norepinephrine